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REVIEW
Abstract: An exacerbation of chronic obstructive pulmonary disease (COPD) is the most common 
respiratory condition necessitating admission to hospital. Many of these are relatively mild in nature 
and as a consequence, there is increasing interest in immediate and early discharge of patients with 
nonsevere exacerbations. Following initial assessment, “hospital at home” or “assisted discharge” 
schemes enable suitable patients with COPD to be discharged into the community earlier than 
normally anticipated. The putative implication is that substantial ﬁ  nancial savings can be made 
in addition to increasing the availability of in-patient beds, without compromising patient care 
or satisfaction. We highlight the current literature which has evaluated the role of hospital at 
home and assisted discharge schemes and discuss our own “real life” service operating in a large 
teaching hospital in Scotland. 
Keywords: chronic obstructive pulmonary disease, management, exacerbations, early support 
discharge schemes, assisted discharge, hospital at home, randomized controlled trial.
Introduction
Chronic obstructive pulmonary disease (COPD) is a common cause of morbidity and 
mortality encompassing large numbers of individuals in both developed and less well 
developed countries. It can place a signiﬁ  cant burden upon patients, families, society, and 
primary and secondary care providers alike. Estimates suggest that COPD will become 
the world’s third leading cause of mortality and the ﬁ  fth most common cause of serious 
morbidity over the next 20 years (Pauwels et al 2001). 
An exacerbation of COPD is deﬁ  ned as a sustained worsening of respiratory 
symptoms that is acute in onset and usually requires a patient to seek medical help or 
alter medication. The deterioration must also be more severe than the usual variation 
experienced by the individual on a daily basis (NCCCC 2004). Exacerbations of COPD 
are the most common respiratory cause for hospital admission and account for around 
10% of all medical admissions in the United Kingdom (Pearson et al 1994; Ashton 
et al 1995). This translates into over 90 000 patients hospitalized each year, with the 
mean duration of stay estimated at 11 days (LAIA 2003). As a consequence, this 
has wide reaching ﬁ  nancial implications for secondary care providers and is likely 
to be implicated in increased hospital bed occupancy and rates of hospital-acquired 
infections. Any intervention which successfully hastens patient recovery and discharge 
from hospital can therefore be seen to be advantageous in the overall management of 
COPD. Indeed, previous data evaluating an assisted discharge service in 241 stable 
elderly medical patients demonstrated a 24% reduction in cost compared with acute 
hospital care (Coast et al 1998). 
In recent years, there has been growing interest in the use of schemes which permit 
patients with relatively mild exacerbations of COPD to be cared for at home. This 
involves selected patients being managed at home after either initial assessment in hospital 
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and immediate discharge, or after several days of in-patient care. 
This evidence-based review highlights the current literature 
regarding the use of hospital at home and assisted discharge 
schemes for patients with exacerbations of COPD. We also 
illustrate our own personal experience of the everyday running 
of such a scheme. 
All authors carried out a comprehensive literature search 
looking for relevant articles published up to April 2006 using 
Medline, Clinical Evidence, and the Cochrane library. The fol-
lowing keywords were used in the search: chronic obstructive 
pulmonary disease, management, exacerbations, early support 
discharge schemes, assisted discharge, hospital at home, and 
randomized controlled trial. Relevant fully published articles 
were then selected and extracted.
Deﬁ  nition
The two commonly used strategies which facilitate the rapid 
discharge of patients back into the community are termed 
“hospital at home” and “early” or “assisted” discharge. Hos-
pital at home involves patients being initially evaluated in a 
rapid respiratory assessment unit in hospital. These units (often 
based in accident emergency or medical admission wards) 
aim to identify individuals with mild exacerbations of COPD 
who can be safely managed at home and as a consequence are 
not generally admitted to hospital. Early or assisted discharge 
schemes allow suitable patients to be discharged before they 
have fully recovered from an acute exacerbation, usually 
within several days after admission to hospital. In both schemes, 
patients remain under the care of the hospital consultant, 
although General Practitioners are informed that their patient 
is back in the community. Multidisciplinary team assess-
ment frequently takes place in both schemes and patients 
are discharged with appropriate medical treatment. Nursing 
support is arranged at home for a variable length of time and 
facilitates the identiﬁ  cation of deterioration in clinical condi-
tion and readmission to hospital if necessary. The putative 
inference is that such schemes could result in reductions in 
length of hospital stay and potential ﬁ  nancial savings without 
compromising patient care and satisfaction or adversely af-
fecting subsequent readmission rates or mortality. 
Trials evaluating the effects
of hospital at home or
assisted discharge
Six randomized controlled trials have examined the effects 
of hospital at home or assisted discharge schemes in patients 
with exacerbations of COPD in terms of readmission rates, 
mortality, quality of life, or length of hospital stay (Table 1) 
(Shepperd et al 1998; Cotton et al 2000; Davies et al 2000; 
Skwarska et al 2000; Ojoo et al 2002; Hernandez et al 2003). 
After discharge into the community, patients in the six studies 
(range of mean forced expiratory volume in one second [FEV1] 
0.69–1.1L) were followed up for a minimum of 2 weeks and 
a maximum of 12 weeks. In all of them, criteria such as those 
suggested by the British Thoracic Society (NCCCC 2004), 
were followed to ensure that patients did not have adverse 
Table 1 Demographics and results of randomized controlled trials evaluating the use of hospital at home or assisted discharge 
schemes
Study  Intervention  N  %  Mean  Mean   Follow   Re-  Mortality  HRQL  Mean 
        age  FEV1  up admission      hospital
      (years)  (litres)  (weeks)  rate      stay
Skwarska   HH  184   25  69  0.74  8  ↔  ↔ NA  NA
et al 2000
Shepperd   HH  32   NA  72  NA  12  ↔  ↔  ↔ NA
et al 1998
Ojoo et al   AD  60  18  70  0.93  2  ↔  ↔ NA  NA
2002
Hernandez   HH or AD  222   35  71  1.1  8  ↔  ↔  ↔  ↓
et al 2003
Davies  HH  150    26  70  0.69 12  ↔  ↔  ↔ NA
et al 2000
Cotton   AD  81   20  66  0.95  9  ↔  ↔ NA  ↓
et al 2000
Abbreviations: AD, assisted discharge; FEV1, forced expiratory volume in one second; HH, hospital at home; HRQL, health-related quality of life; N, total number of 
randomized subjects with COPD; NA, not documented or not measured in the study; ↔, no signiﬁ  cant difference with active intervention versus conventional in-patient 
care; ↑, signiﬁ  cant improvement with active intervention versus conventional in-patient care; ↓, signiﬁ  cant reduction with active intervention versus conventional in-patient 
care; %, percentage of screened patients suitable for AD or HH. International Journal of COPD 2006:1(4) 403
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clinical parameters or social circumstances which might 
have indicated that in-patient care was more appropriate. It 
is also important to note that in all of the studies, a signiﬁ  cant 
number of patients needed to be screened so suitable patients 
with mild exacerbations of COPD without serious concomi-
tant disease processes or adverse social circumstances were 
identiﬁ  ed (Table 1). For example, in one of the studies with 
the greatest number of randomized patients, 718 individuals 
with a diagnosis of exacerbation of COPD over an 18 month 
period, were assessed for inclusion and only 184 (26%) 
were considered suitable (Skwarska et al 2000). Reasons for 
patients not being eligible for study entry included presence 
of adverse clinical parameters (chest radiograph abnormality, 
confusion, impaired level of consciousness, pH <7.35; 50%), 
serious medical co-morbidity (19%), refusal to participate 
(3%), and adverse social circumstances (2%). 
Mortality and need for readmission
All six trials measured mortality rates and need for readmis-
sion between patients incorporated into either hospital at 
home or assisted discharge schemes versus those receiving 
conventional hospital-based care (Shepperd et al 1998; Cotton 
et al 2000; Davies et al 2000; Skwarska et al 2000; Ojoo et al 
2002; Hernandez et al 2003). No signiﬁ  cant differences were 
observed between groups although it is important to point 
out that the follow-up period was limited to a maximum of 
12 weeks. 
Reducing length of in-patient stay
The effectiveness in terms of reduced length of hospital stay 
was speciﬁ  cally evaluated in two randomised controlled 
trials (Cotton et al 2000; Hernandez et al 2003). In one study 
(Cotton et al 2000), 41 patients with a nonsevere exacerba-
tion of COPD were randomly allocated to early discharge and 
40 were allocated to conventional in-patient management. 
Patients were visited on the day after admission by a specialist 
respiratory nurse and at intervals considered appropriate there-
after. Those in the early discharge group had a mean hospital 
stay of 3.2 days (range 1–16 days) while those in the conven-
tional group had a mean stay of 6.1 days (range 1–13 days). In 
another study, Hernandez and colleagues (2003) evaluated the 
effects of randomly assigning 222 patients with COPD to either 
conventional in-patient care or immediate or early discharge. 
The desired period of follow-up was chosen by a respiratory 
nurse with a maximum of 5 visits at home permitted over an 
8 week period with unlimited telephone access. Conventional 
care resulted in a greater length of hospital stay amounting to 
4.2 days versus 1.7 days in the early discharge group (p < 0.001 
for the difference).
Acceptability 
Hospital at home and assisted discharge schemes have been 
shown to be acceptable both to patients and healthcare 
workers. On the completion of their randomized controlled 
trial, Skwarska and colleagues (2000) obtained questionnaires 
on general satisfaction with their assisted discharge scheme. 
Sixty nine percent of patients treated at home and 55% of 
their General Practitioners responded to questionnaires. The 
vast majority of patients (95%) were “completely satisﬁ  ed” 
with the service and 90% felt that they had been cared for 
“just as well or better” at home than they would have been in 
hospital. Moreover, all General Practitioners who responded 
were satisﬁ  ed with the provision of domiciliary support for 
patients with mild exacerbations of COPD, while 65% felt 
that doing so did not increase their workload. In another 
study, satisfaction scores demonstrated similar mean scores 
for home management (92%) versus conventional hospital 
based management (88%) (Ojoo et al 2002). In the study by 
Hernandez and colleagues (2003), patients managed at home 
also had a higher satisfaction score than those assigned to 
hospital care.
Effects upon quality of life
Effects upon health-related quality of life were assessed in 
three trials (Shepperd et al 1998; Davies et al 2000; Hernandez 
et al 2003). In one study, the St George’s respiratory 
questionnaire (SGRQ) was assessed during the ﬁ  rst week 
of the exacerbation and after 3 months of follow up (Davies
et al 2000), with no signiﬁ  cant differences observed between 
groups. In another study (Hernandez et al 2003), there was 
a greater, although statistically nonsigniﬁ  cant (p = 0.05) 
improvement in SGRQ score in patients treated at home 
than in the control group. Shepperd and colleagues (1998) 
obtained questionnaires on general health status and respira-
tory health status at the beginning and following 3 months 
of follow up. There were no signiﬁ  cant differences in scores 
between individuals managed at home compared with those 
receiving conventional in-patient care.
Cost effectiveness
An indirect cost calculation carried out in Lothian, Scotland 
showed that the cost of an early supported discharge scheme 
was £877 versus £1753 for a hospital admission due to an acute 
exacerbation of COPD (Skwarska et al 2000). In a randomized International Journal of COPD 2006:1(4) 404
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controlled trial comparing the cost of hospital at home care 
versus in-patient hospital care for patients recovering from 
hip replacement, knee replacement, and hysterectomy, elderly 
medical patients and COPD, there were signiﬁ  cantly greater 
healthcare costs for home managed patients with the latter 
(Shepperd et al 1998), although the numbers of patients included 
were small (n = 32). However, in a larger study (n = 222), 
the overall cost for an 8 week hospital at home service was 
62% that of the cost of conventional in-patient management 
(Hernandez et al 2003). An Australian study of patients 
with an exacerbation of COPD (n = 25) primarily evaluated 
the comparative cost of home-based care with traditional in 
patient care. The group randomized to home care cost 30% 
less (p < 0.01 for the difference) than those who received 
in-patient management (Nicholson et al 2001).
Our own experience
Aberdeen Royal Infirmary is a large teaching hospital 
(n = 952 acute admission beds) situated in the North East of 
Scotland with a catchment population of 523,400 patients 
(city centre population 212,200). Due to the practical dif-
ﬁ  culties of traveling long distances and possible need for 
re-admission, individuals with mild exacerbations of COPD 
are only considered suitable for assisted discharge if they 
live within a 30-mile radius of the base hospital. All data 
from patients enrolled into our early discharge scheme are 
stored electronically in a secure database accessible only by 
passwords known exclusively by relevant staff. The data 
shown in Table 2 illustrates the numbers of patients entered 
into our own assisted discharge scheme between January 
2002 to December 2005 and shows that only a relatively 
small proportion required readmission to hospital. As can 
be observed from Table 3, many patients were willing to 
be incorporated into our assisted discharge scheme during 
subsequent re-admissions to hospital. 
Patient suitability
Patients are ﬁ  rstly assessed in hospital by a specialist registrar 
or consultant in respiratory medicine. This varies between 
several hours after arrival in an acute admission ward to sev-
eral days of in-patient care in a general medical or respiratory 
ward. During this contact period, clinical condition along 
with laboratory and radiology results are assessed, treatment 
optimized, and overall suitability discussed with both the 
patient and nursing staff. It is not necessary for a given patient 
to be under the direct care of, or have previous contact with, 
a respiratory physician. Factors which prevent patients from 
being discharged earlier from our own hospital are shown in 
Table 4. 
Community management and follow up
Prior to starting our service in 2001, all General Practitioners 
were provided with written information outlining the assisted 
discharge scheme (Figure 1). The General Practitioners of all 
patients entering the scheme are informed by fax on the day 
of their discharge back into the community. This also allows 
changes in treatment, diagnosis and results of investigations 
to be communicated. Thereafter, General Practitioners only 
become involved in a patients’ care if a nonrespiratory problem 
is encountered throughout the subsequent assisted-discharge 
period. 
After discharge from hospital, nursing advice   — by home 
visit or by telephone — is available on a 24 hour basis for a 
minimum of 7 to a maximum of 14 days. If required, oxygen 
cylinders and nebulizers are given for short-term use during 
Table 2 Numbers of patients (mean age 72 years) with mild 
exacerbations of COPD entered into our own assisted discharge 
scheme and frequency of readmission to hospital
Year  Number of assisted  Number of times
  discharge episodes  readmission required
2002 207  13
2003 199  22
2004 184  6
2005 220  18*
Total over 4 years  810  59
Table 3 Numbers of patients having single and repeat episodes 
of assisted discharge for mild exacerbations of COPD over a 
3 year period 
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this period, the use of which is monitored by respiratory 
specialist nurses. Currently, a team of 7 nurses are available 
to conduct the daily visits which take place at an agreed time 
suitable for all relevant parties. During home visits, patients’ 
physiological observations (temperature, blood pressure, 
pulse, respiratory rate, oxygen saturation, and peak expiratory 
ﬂ  ow rate) are recorded and the patients’ progress discussed. 
When necessary, intravenous antibiotics are administered 
and venepuncture carried out to check, for example, 
aminoglycoside levels. If at anytime during assisted hospital 
discharge a patients’ progress is considered unsatisfactory, 
re-admission to hospital can be arranged by the nurse directly 
to the respiratory ward (Table 2). All individuals entered 
into the scheme are given an appointment to be reviewed at 
a respiratory out-patient clinic 1 month following assisted 
discharge.
Patient satisfaction
All patients embarking on their initial episode of assisted 
discharge are asked to ﬁ  ll in a satisfaction questionnaire. 
Of those questionnaires returned between 2002–2005, more 
than 90% felt that their “overall satisfaction with the service 
provided at home” was between 8–10 on a 10 point scale.
Funding
In December 2001, funding of £86,000 was initially allocated 
from the Scottish Executive’s Winter Planning Initiative. This 
agreed amount was given to pilot an early assisted discharged 
scheme for 3 months for patients admitted to hospital with an 
exacerbation of COPD. Following the success of the pilot, NHS 
Grampian continued to fund the service on a “non-recurring 
basis”. In 2005, this service was integrated into respiratory 
medicine with recurring annual funding of £200,000.
Conclusion
Current randomized controlled trials evaluating hospital at 
home or assisted discharge schemes for patients with mild ex-
acerbations of COPD suggest that they do not result in patients 
requiring readmission and are not associated with an increased 
mortality rate over a 12 week period. Moreover, patients gener-
ally ﬁ  nd them an acceptable alternative to hospital admission 
although it is important to point out that many patients with an 
Table 4 Clinical features and social circumstances considered unsuitable for entering patients into our own assisted discharge 
scheme
Clinical features  Social circumstance
Confusion No  telephone
Worsening peripheral oedema  Patient, family, or General Practitioner unwilling
pH <7.35, pO2 < 8 kPa, pCO2 > 6.5 kPa   Home > 30 miles from base hospital
Heart rate > 110 beats per minute  Adverse home circumstances
Respiratory rate > 28 breaths per minute
Unable to complete sentences 
Undiagnosed or cardiac chest pain 
Abbreviations: pCO2, partial pressure of carbon dioxide ; pO2, partial pressure of oxygen.
Figure 1 Algorithm describing proposed protocol for entering patients into 
assisted hospital discharge. 
Abbreviation: COPD, chronic obstructive pulmonary disease. 
Patient admitted with an exacerbation of COPD
Assessment by a middle grade or consultant 
respiratory physician
Absent adverse clinical parameters
Patient, family and General Practitioner agreeable 
to early hospital discharge
Hospital discharge with nurse led follow up
 for 1–2 weeks Clinical progress discussed with
 respiratory physician if required
Optimised pharmacological treatment
Out-patient review 1 month after assisted dischargeInternational Journal of COPD 2006:1(4) 406
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exacerbation of COPD are not suitable for inclusion in such 
schemes. Several of the studies high-lighted in this review 
have also shown considerable ﬁ  nancial savings as compared 
with conventional in-patient care.
In a meta-analysis of randomized controlled trials 
(n = 754 patients), Ram and colleagues (2004) evaluated the 
overall efﬁ  cacy of hospital at home schemes. This demon-
strated that hospital readmission (relative risk [RR] 0.89, 95% 
conﬁ  dence interval [CI] 0.72 to 1.12) and mortality rates (RR 
0.61, 95% CI 0.36 to 1.05) were not signiﬁ  cantly different when 
hospital at home or assisted discharge schemes were compared 
with standard in-patient care. As anticipated, substantial ﬁ  nan-
cial savings were made along with the increased availability 
of in-patient beds. It is important to point out that in the same 
meta-analysis (Ram et al 2004), only 1 out of every 4 patients 
presenting to hospital were eligible for inclusion, although it 
possible that due to strict study entry requirements, this ﬁ  gure 
may not be completely reﬂ  ective of “real life”.
Despite these clear advantages, hospital at home or 
assisted discharge services are not generally in wide-
spread use in hospitals throughout the UK. For example, a 
postal questionnaire was sent to consultants in 223 different 
respiratory departments in the UK in 1999. Although over 
90% of consultants were aware of early discharge schemes, 
in only 16% of departments was such a service in place with 
difﬁ  culty in securing adequate funding the main reason for 
not having one (Johnson et al 2001). However, in a UK-based 
national COPD audit in 2003, 44% of hospitals did in fact 
have an immediate or early discharge service of some sort 
available (Quantril et al 2005). Greater emphasis should 
perhaps be made of such schemes in national published 
guidelines in addition to provision of a suggested work-
ing framework (NCCCC 2004). Indeed, it is increasingly 
important that all practicing respiratory physicians and health 
authorities are made aware of the existence of hospital at 
home and assisted hospital discharge schemes and of the 
potential ﬁ  nancial savings involved. 
Our own experience and data suggests that assisted 
hospital discharge schemes can result in reductions in the 
length of hospital stay for patients with COPD, as the mean 
length of stay in our hospital is now 4 days. Moreover, we 
have also extended our service to incorporate patients with 
other chronic respiratory disorders such as bronchiectasis, 
interstitial lung disease, and chronic asthma (Currie et al 
2005). We feel that part of the success of our own scheme 
is related to the meticulous screening and appropriate 
selection of patients for inclusion (Table 4). It is known 
that the mortality from COPD on admission to hospital is 
closely linked to the degree of acidosis (Warren et al 1980) 
and presence of concomitant medical disorders (Seneff et al 
1995; Connors et al 1996). As a consequence, patients with a 
pH <7.35 are not considered suitable for assisted hospital 
discharge, although we do not exclude patients with other 
medical disorders such as ischemic heart disease, diabetes 
mellitus or cardiac failure who are considered to be clinically 
stable. However, it is important to note that one patient with 
end-stage COPD died while on our own assisted discharge 
scheme, although this may not have been preventable with 
in-patient care. 
In conclusion, hospital at home and assisted discharge 
schemes facilitate a safe and effective means by which to dis-
charge patients with mild exacerbations of COPD back into 
the community and may result in potential ﬁ  nancial savings 
and reductions in bed occupancy. We have also shown that 
such schemes —which have been shown to be effective in the 
realms of randomized controlled trials — can be successfully 
incorporated into the “real life” management of patients. It is 
important that templates determining which patients may be 
safely incorporated into assisted discharge schemes are for-
mulated and that they are delivered by appropriately qualiﬁ  ed 
nursing and medical personnel. Factors which are associated 
with re-admission to hospital or patient dissatisfaction also 
require to be audited frequently. Perhaps in the future, hos-
pital at home and assisted discharge schemes can be linked 
up with intensive pulmonary rehabilitation programmes and 
encouragement of patients to maintain as high a level of physi-
cal activity in their daily life as possible, both of which are 
known to have beneﬁ  ts in the overall management of COPD 
(Garcia-Aymerich et al 2003; NCCCC 2004).
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